BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32819275)

  • 1. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
    Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
    Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.
    Zhou M; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Xing Y; Zhao D;
    Cardiovasc Diabetol; 2018 Nov; 17(1):147. PubMed ID: 30482187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project.
    Wang W; Yang J; Wang K; Niu J; Liu Y; Ge H;
    Cardiovasc Diabetol; 2024 May; 23(1):170. PubMed ID: 38750553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of glycated hemoglobin in acute coronary syndrome patients from the CCC-ACS project : Findings from a multicenter retrospective observational study.
    Zhao X; Kang Y; Wang X; Yang X; Ai G; Liu Y; Xu P; Zhang J; Gu C; Zhang Y; Hao Y; Zhao D; Han Y;
    Herz; 2021 Sep; 46(Suppl 2):287-294. PubMed ID: 33231709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry.
    Cui K; Fu R; Yang J; Xu H; Yin D; Song W; Wang H; Zhu C; Feng L; Wang Z; Wang Q; Lu Y; Dou K; Yang Y;
    Cardiovasc Diabetol; 2023 Jul; 22(1):165. PubMed ID: 37403082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA
    Shahim B; De Bacquer D; De Backer G; Gyberg V; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L
    Diabetes Care; 2017 Sep; 40(9):1233-1240. PubMed ID: 28637653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome.
    de Mulder M; Oemrawsingh RM; Stam F; Boersma E; Umans VA
    Heart; 2012 Jan; 98(1):37-41. PubMed ID: 21708819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
    Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
    J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
    Kmet M; Rajer B; Pernat A
    Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.
    Sun X; Du T; Huo R; Xu L
    Acta Diabetol; 2014; 51(3):353-60. PubMed ID: 24072380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.